FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

38738411000001105: Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1504601000001117 Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1504621000001112 Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Is a Levonorgestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has AMP Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start